Sitemap - 2023 - The Kable

💊 US FDA approves first gene therapies for sickle cell disease; Congo’s mpox outbreak worries WHO; Long Covid afflicts half of African Covid survivors

💉 Gavi Board approves the AVMA; Contaminated syrups detected in 4 WHO regions; US FDA’s drug recall posting spree

💊 No HIV vaccine this decade; No good mosquitoes for Indonesia yet; No lessons learnt from African outbreaks

💊 Gavi's new vaccine programmes; CEPI, Jurata partner for needle-free vaccines; AbbVie, Sanofi's love affairs with AI

💊 Aspen Pharma’s Chinese acquisition; The AMA journey so far; Drought a planetary scale emergency

💊 A historic Declaration of Climate and Health; A global dengue fever nightmare; The epidemic of autoimmunity

💉 AbbVie acquires an ovarian cancer ADC; WHO releases its World Malaria Report; FIND, Rwanda Biomedical Centre accelerate diagnostic innovation

💊 Africa Epidemics Fund in the making; Clinical trial capacity for West Africa; Boehringer collab pulls Phenomic AI into the spotlight

💊 CHAI’s vaccine market-shaping strategy for Africa; BMS expands its Avidity partnership; Boehringer, Amgen get in on genAI

💊 CPHIA kicks off in Zambia; Lilly wins over Novo Nordisk in obesity arena; Fiocruz, Anlis to produce yellow fever shots in Argentina

💊 Vaxxas’ novel vaccination tech; India makes more cheap drugs; South Korea encourages biopharma investments

💉 Carisma’s undercover cancer-killers; Moving from pollution to solutions in Africa; XtalPi’s Singapore connection

💊 Korea's IVI, KAIST collaborate on vaccine research; Boehringer Ingelheim acquires Swiss biotech; Malaria shots arrive in Cameroon

💊 Moderna's patent loss; Making drugs for kids; Fighting climate change for children

💊 An emissions canyon; A shot in the dark?; A MAP for East Africa

💊 After GSK exit, Nigeria drug prices soar; ViiV’s CAB-LA still too expensive for SA; Jamjoom expands in Egypt

💉 Fruity flavours to prevent MDR-TB; UKDRI funding for neurodegeneration research; US FDA approval for BMS' cancer therapy

💊 Sinovac scraps Bangladesh project; Gilead subsidiary expands Arcellx collab; Acuitas sues CureVac over LNP tech patents

💊 Pfizer spreads some pre-Christmas cheer; Jazz and Autifony shake hands; Almirall digs deep in AI with Absci

💊 Nigeria to set up a vaccine plant; Novartis gets into bed with Legend; Ajinomoto spices up with Forge

💊 Novo Nordisk goes big on expansions; Verve turns to base editing for cholesterol; The WHO profiles vaccines

💉 Valneva's Ixchiq the first approved chikungunya vaccine; Moderna, others leveraging mRNA magic; Takeda gets two FDA approvals

💊 The end of Sanofi’s Nigerian sojourn; Africa’s air pollution a global problem; The hazards of toiling under the sun

💊 Kenya's Universal Corporation plots a lifeline against malaria; AbbVie, GSK, others under FTC fire; Bayer's incubator network expands

💊 BMS' new next-gen ADC; Moderna's mRNA network; BioNTech's Chinese purchase

💊 BioNTech acquires AexeRNA; Shionogi, Apnimed make a baby; EFPIA says nein to new pharma rules

💉 Bayer causing cancer, curing cancer; CEPI and Oxford vs Junín virus; A CERCLE for equitable research

💊 IVI, partners train African vaccine manufacturing workers; A new Alliance for mRNA Medicines; AstraZeneca's cell and gene therapy partnership

💊 Merck goes to Korea for AI; Lilly plunks down big bucks; Achieving health equity in Africa

💊 The UK’s new life sciences accelerator; Novartis’ bet to pay off; Eli Lilly shoots for the stars

💊 Morocco’s new vaccine quality control lab; Uganda’s local diabetes drug production; Our fragile state of pandemic preparedness

💉 A potential threat to the world's generics supply; Pfizer, BioNTech's promising combo vaccine; Sanofi's spin-off of its consumer health business

💊 India's Himalaya Wellness goes to Dubai; Brazil scientists develop a cocaine addiction vaccine; AREF, Roche launch fellowship in Africa

💊 Mosquirix reduces child deaths in Africa; The EC fines an API cartel; BMS goes to China

💊 Roche settles patent lawsuit against Biogen; Merck switches up its ADC portfolio; LLMs perpetuate race-based medical minisformation

💊 Roche goes shopping at Roivant; Johns Hopkins makes people sick for science; Duke University fights all coronaviruses with one shot

💉 Merck grabs a share of Daiichi's ADCs; WHO's new anti-AMR intervention package; More royalties for Royalty Pharma

💊 Tracing the evolution of bird flu; AI finds cure for osteoporosis in malaria drug; Doherty Institute joins CEPI lab network

💊 A Pandemic Accord draft no one can agree on; Bangladesh breaks its own record; Merck's Keytruda achieves a first

💊 An immunisation action plan for Africa; Malaria diagnostics for Angola; Bedbugs for the world

💊 Ayurveda hopes to go global; An evolving toolkit against antibiotic resistance; No treatment, only toxins in Indonesian cough syrups

💉 A human brain cell atlas; BioNTech’s latest ADC investment; Daiichi Sankyo’s mRNA combo shot

💊 Marion Biotech gets a second chance; BMGF, partners put polio on exit route; UNICEF secures malaria vaccine supply

💊 WHO roadmap to protect maternal lives; ADB funding to help Bangladesh make vaccines; Sanofi’s BioMap deal to further AI drug discovery

💊 Kenya looks to buy drugs locally; Gates Foundation funds mRNA tech for Africa; Lancet says strokes will kill many

💊 BMS beats Sanofi to acquire Mirati; The Indian Pharmacopoeia Commission marks a milestone; The good, the bad and the ugly of GLP-1s

💉 AbbVie's Parkinson's purchase; Emergex's Saudi sojourn; Promosome's patent case dismissal

💊 Dengue ventures far from home; Moderna kills two birds with one stone; Lotte Biologics enters Korean economic zone

💊 Eli Lilly earns a Point; AstraZeneca settles in heartburn drug lawsuit; Mastercard, Africa CDC halt Covid programme funding

💊 Oxford malaria shot gets WHO pre-qualification; Sanofi joins Janssen in the fight against E. coli; Soil heat an underestimated risk

💊 LMICs free from J&J’s TB drug patents; Malaria vaccine likely to get WHO approval; ModeX wins BARDA contract

💉 AfDB's country reports to guide climate talks; Yamaha revs into healthcare; Routine immunisation rebounds

💊 Ginkgo, Pfizer's new RNA collab; The cost of clean air; Throwing DARTS at resistant bacteria

💊 J&J’s new incubator in Singapore; India’s new policy for pharma, medtech R&D; The US FDA takes no chances

💊 Zimbabwe's diaspora-supported biotech city; Counterfeit drugs in Pakistan; Looking down our drains

💊 BioNTech revises Africa plans; World leaders revise TB targets; Cholera doesn't revise global plans

💉EuBiologics transfers tech to Biovac; Evaxion collaborates with Afrigen Biologics; Egypt cooperates with Africa on health

💊 A historic, non-binding pandemic declaration; India tries to build back pharma trust; Repeat offender Novartis under PMCPA fire

💊 Novo dials up Aspen for insulin for Africa; Novartis dials down another deal with BeiGene; Bio Farma partners CEPI

💊 BioNTech to advance mpox vaccine; Sanofi to offload CNS drugs; GSK gets an FDA nod

💊 Germany finances vaccine development in South Africa; Uganda hopes to locally develop FMD vaccine; US NIH begins testing universal flu shot

💉 The Asia-Africa cholera corridor; Mpox joins China's Category B; J&J sheds its old skin

💊 Moderna’s lofty goals; WHO-WTO-WIPO’s TRIPS focus; Takeda’s new global CSR commitments

💊 GARDP, Orchid Pharma widen antibiotic access; Google’s funds SDG-focused AI projects; US FDA cracks down on unapproved eye drug marketing

💊 Malaria escapes detection, treatment in Ethiopia; Goalkeepers Report calls for action on maternal, newborn health; Another pandemic scare

💊 FuturizeU incubator for African health tech; Download the new Kable Report on SSA & MENA; SK Bioscience collaborates with Serbian government

A Luminous Biopharma Future for SSA and MENA

💉 Seagen, Nurix marry cancer-fighting tech; Sanofi India wants to make polio vaccines no more; Paige, Microsoft get in on AI-based cancer diagnosis

💊 Africa proposes global carbon tax; Mexico decriminalises abortion; A(nother) potential pandemic in the making

💊 South Africa’s Covid contracts revealed; Uganda makes its own morphine; A WHO toolkit for air pollution and health training

💊 Africa’s push for climate investment; Ghana to make its own cholera vaccines; Japan’s Otsuka to acquire Canada’s Mindset

💊 KEMRI teams up with Kenya Biovax; The Dengue Alliance sets an ambitious goal; Climate change has harsh impacts on African children

💉 Japan's Ono partners with US' Twist; Wellcome's 7-year grant for Africa Health Research Institute; India looks to privatise Indian Medicines Pharmaceutical Corp

💊 World Bank funds primary healthcare in Bangladesh; J&J and Lupin slash TB drug prices; The Global Fund makes HIV treatment cheaper

💊 Africa’s call for increased malaria investment; Africa’s regional AMR strategy; Kenya’s bid to move away from donor support

💊 Lifera’s JV with Resilience; A challenge to Moderna’s Covid vaccine patents; CEPI funds Disease X vaccine development

💊 The last roll of the HIV vaccine dice; South Africa's combination vaccine success; Bayer's Parkinson's therapy success

💉 Trade talks threaten medicine materialisation; Y chromosome unmasked; AbbVie drops ADCs from pipeline

💊J&J shuts down a vaccine unit; GSK looks to shut down Moderna's vaccine trademark; The WHO wants to shut down junk food at stadia

💊 Satio’s new Ebola diagnostic; WHO’s decision-making tool repository; $1.4 billion for next-gen Covid therapies, vaccines

💊 Indonesia and Kenya’s health sector partnerships; Saudi Arabia’s new NIH; The PATH to better health service financing

💊 WHO’s new digital health guide; Africa CDC’s push for diagnostics access; Lupin’s new diabetes brands

💉MSF asks ViiV to leave conditions at the door; SK Biopharma heads to the Middle East; WHO goes all in on traditional medicine

💊 The end of Malawi’s cholera outbreak; COFEPRIS’s boost to Mexican biopharma production; Mosquito-borne disease surveillance for the Americas

💊 Life Semantics’ entry into LatAm; Indian Health Ministry’s pharma ambitions; Gilead’s shiny, new deal

💊 LifeArc invests in African scientists; WuXi Biologics partners with Boostimmune; Pfizer gets accelerated approval for myeloma antibody

💊 Uzbekistan begins trial over cough syrup deaths; AbSci, Caltech get BMGF funding for HIV vaccine; J&J’s Talvey gets accelerated approval

💉Africa CDC donates equipment to SAHPRA; WHO to convene Traditional Medicine Global Summit; Novo Nordisk diversifies its obesity drugs

💊 A new Covid variant of interest; Regeneron's new acquisition; AstraZeneca goes greener

💊 CEPI funds Gennova's Disease X vaccine development; DualityBio and BioNTech expand collab; SK Bioscience claims Novavax stake

💊 Ginkgo partners with Merck; Nektar Therapeutics sues Eli Lilly; WHO issues a cold syrup alert

💊 Sanofi partners up with Middle East's PureHealth; US FDA issues guidance on nitrosamine impurities; Doctors Without Borders end longest-running Malawi project

💉 GSK Nigeria to cease operations; Blackstone to bid for Cipla stake; Bavarian Nordic secures BARDA contract for smallpox/mpox vaccine

💊 Biogen looks to sell biosimilars business; GSK sues Pfizer over RSV patents; Who cares about pharma quality?

💊 Intas Pharmaceuticals' trouble with the FDA; Aspen's Latin American affair; Emergent BioSolutions' Ebola treatment contract

💊 The US FDA's regulatory collabs; GSK's new APAC vaccine distribution hub; Gilead's hepatitis grant programme

💊 Africa CDC's grouse with Pandemic Fund allocations; Biogen bulks up in rare disease department; AstraZeneca's new gene therapies

💉 Bloomberg's drug quality investigation; Extreme heat's effects on women; Merck's pneumococcal vaccine success

💊 WHO updates Essential Medicines List; Misinformation threatens malaria vaccine uptake in Africa; Moderna, Merck recruit for phase 3 cancer vaccine trial

💊 Astellas to gain cancer therapy partner; Biogen to lose part of workforce; India to retain pharma export market

💊 Africa maps AMR; Vietnam approves swine fever shots; UN Sec-Gen bemoans broken food systems

💊 Roche and Alnylam's hypertension collab; WHO warns of dengue's pandemic potential; The Gambia's push for pharma quality

💉 Big Pharma fearless against future pandemics; Sanofi signs on Recludix as partner; US FDA approves anthrax shot

💊 Adult vaccination rates fall, says GSK; Tainted cough syrup in Cameroon, says WHO; No funding to WIV, says US HHS

💊 Pfizer and Flagship's new collab; Africa's new Health Security Partnership; A silent epidemic in Africa

💊Novo Nordisk inks RNA research deal; Sanofi delves deeper into gene editing; Novartis plots a biotech buy

💊 African Risk Capacity builds resilient health systems; Eli Lilly acquires Versanis Bio; Ghana approves cannabis cultivation

💉 Investigating India’s Galentic Pharma; Ending AIDS by 2030; Making generic TB drugs

💊 WHO prequalifies conjugate meningitis shot; Boehringer Ingelheim to supply France with bird flu shots; Novartis violates UK marketing standards

💊 Takeda withdraws Qdenga's US FDA application; BMS' licensing agreements with Evotec, Prothena; BioNTech's Chinese connection

💊 EMA investigates GLP-1 agonists' suicide risks; Bayer and Peking Uni extend partnership; As do Novartis and Samsung Biologics

💊 GSK's RSV shot approved in the UK; Coloplast gets up to fishy business; Varda makes drugs in space

💉 Another Bausch + Lomb purchase; VBI Vaccines and Brii Biosciences' hep B partnership; US FDA's updated risk-based inspection model

💊 Malaria vaccines for Africa; Sanofi's Saudi Arabian sojourn; A new UK Rare Disease Research Platform

💊 Africa CDC helps Cameroon with genomic surveillance; WHO warns against harmful food marketing; Moderna makes Chinese inroads

💊 AfDB invests in African pharma and more; More copycats for AbbVie’s Humira; Africa CDC partners with US Pharmacopoeia Convention

💊 US FDA approves haemophilia A gene therapy; Novartis sells its dry eye drug; Australia approves medical trips

💉 Eli Lilly on a buyout spree; Sanofi optimistic about vaccine sales; Aurobindo Pharma’s quality lapses

💊 BMGF funds phase 3 for TB shot; Roche gets FDA green light for Alzheimer's diagnostic; Sanofi works on next-gen mRNA tech

💊 Gavi and partners' experimental vaccine stockpile; BMS gets European approval for Camzyos; Sanofi's eczema drug sees promising mid-stage results

💊 COVAX sits on a fat bank balance; Pfizer drops a weight loss candidate; Eli Lilly's drug helps drop weight

💊 Health Impact Investment Platform for LICs and LMICs; MPP sub-license agreements for Covid antivirals; US FDA draft guidance on medical trips

💉 Sarepta Therapeutics’ Duchenne therapy gets accelerated approval; MPP grants sub-licenses for Nilotinib generics; Diabetes rates only going up

💊 Lupin to launch COPD generic in the US; Bangladesh to set up its first vaccine-making facility; The WHO says El Nino will bring disease

💊 Eli Lilly acquires Dice Therapeutics; The Gambia wary of Indian pharma; Bavarian Nordic’s chikungunya vaccine succeeds in phase 3 trial

💊 CEPI invests in Nipah research; Daewoong makes its way to Africa; Vaxxas’ new Australian Biomedical Facility

💊 AstraZeneca hiving off China business; Moderna getting deeper into rare diseases; Saudi Arabia launches firm to boost local manufacturing

💉 Eli Lilly and Verve target Lp(a); Astellas partners with Cullgen on protein degraders; Valneva retires manufacturing plant

💊 Sanofi all in for AI; The Council of the EU takes on AMR; IPD builds biomanufacturing capacity

💊 AstraZeneca gets greener with Vanguard; Gavi gets optimistic about childhood immunization; Pfizer gets low on penicillin products

💊 Novo Nordisk expands its manufacturing capacity; German court postpones BioNTech hearing; Africa loses faith in vaccines

💊 Novartis acquires Chinook in boost to pipeline; AstraZeneca signs up with Quell to Treg diabetes; The UN says gender bias (surprisingly) still exists

💉 Samsung to make Pfizer drugs; Marburg no longer an outbreak in Equatorial Guinea; AfDB's new grant for rural healthcare in Morocco

💊 Moderna to begin mpox vax human trials; WHO to track TB research; A swine fever vaccine emerges in Vietnam

💊 Sanofi, AZ on track to get RSV therapy approval; Fosun Pharma to make drugs in West Africa; WHO’s integrated climate-health research agenda

💊 AstraZeneca’s Andexxa prevents intracranial bleeding; Bayer and Acuitas team up for LNPs; US FDA tackles cancer drug shortage

💊 Janssen’s Covid vaccine EUA revoked; GSK promotes adult vaccination uptake; Who trusts pharma?

💉 AstraZeneca, Merck’s Lynparza gets FDA thumbs up; WHO’s drug dependence resource repository; Climate financing for gelato

💊 Novo Nordisk, Lilly looking at big obesity bucks; Pfizer’s RSV shot gets FDA approval; HPV shots to get cheaper

💊 Phase 3 success for Pfizer’s haemophilia drug; An Eli Lilly x XtalPi collab; Bird flu’s new North American look

💊 ADCs to grab the limelight at ASCO; Global hunger worsens; Menstrual health review from East Asia and the Pacific

💊 The UK’s Life Sci for Growth package; The WHO’s new NCD best buys; Korea’s new global biomanufacturing training hub

💉 Novo Nordisk’s gene editing collab; Africa CDC, WHO’s joint emergency preparedness plan; Nigeria’s health service crisis

💊 An overstretched WHO response; The need for new Covid-fighting antibodies; A respiratory disease emergency in Brazil

💊 AstraZeneca gets Revvity’s gene editing tech; Amgen and Janssen reach patent case settlement; What’s up with the pandemic treaty?

💊 Novartis expands gene therapy pipeline with Avrobio buy; Thermo Fisher expands into Singapore; Ironwood spends $1 billion on short bowel syndrome

💊 Moderna reports positive news from PA trials; New Covid vaccine trials in China; Death toll from the pandemic? 337 million

💉 The WHO’s new Covid vaccine recommendations; Medtronic’s India expansion; Pfizer’s antibiotic warnings

💊 EMA issues guidance for industry to tackle drug shortages; Astellas and Sony’s ADC partnership; Scribe inks research collab with Lilly subsidiary

💊 Google launches new AI drug discovery tools; WHO urges caution on AI in healthcare; Amgen's Horizon deal sees trouble on the horizon

💊 AstraZeneca and LaNova team up against myeloma; Gilead and Arcus renew their vows; WHO reports on the fight against AMR

💊 WHO calls for accelerated anaemia action; India gets world-first oral cholera LDPE unidose vaccine; Cut patent, cut price

💉 Lessons from Aspen's vaccine production failure for Africa; New funding for blood therapies; Mpox no longer an emergency

💊 India's Doceree expands into Southeast Asia; Sweden's Sobi buys CTI BioPharma; Pfizer takes cancer testing to LatAm, Africa, the Middle East and Asia

💊 Roche goes shopping in China; Gilead’s foray into oncology and inflammation; The state of global pre-term births, by the WHO

💊 Eisai and Bliss Biopharma’s new ADC collab; Boehringer and Ginkgo on the lookout for new therapeutics; Baxter sheds Biopharma for $4.5 billion

💊 Pandemic who? WHO ends Covid emergency; Lupin’s new French connection; Sudan loses a million polio shots

💉 Moderna breaks ground in the Philippines; Valneva's Lyme disease vaccine gets pushed back; Sandoz bulks up with more generics

💊 Big yay for GSK; Thumbs up for Eli Lilly’s Alzheimer’s drug; BMGF plots access to childhood shots

💊 J&J gains two new lymphoma therapies; Pfizer dumps three drug candidates; US provides draft guidance for decentralised clinical trials

💊 Third time’s a charm for Sanofi and Pompe disease; Medtronic’s next-gen pacemakers get FDA green light; No mo’ mpox in the US

💊 Japan’s Astellas goes shopping in the US; Pfizer struggles with getting RSV vaccine to LMICs; International consortium CAMO-Net fights AMR

💉 Winner in sight for RSV race; AstraZeneca dumps $855 million rare disease drug; Eli Lilly sees success in obesity drug trial

💊 EU proposes changes to pharma laws; India approves new medical devices policy; Malaysia gets traditional medicine research framework

💊 Novartis and Biogen cut down on R&D; Biological threat in Sudan; Bird flu transmission in mammals

💊 Eli Lilly lets go of emergency hypoglycaemia drug; WHO, BMGF catching up with vaccination coverage targets; Who’s buying from Africa?

💊 Sun Pharma and Hetero Labs issue recalls in the US; South Africa gets a state-of-the-art Biomedical Research Institute; Abbott preps for climate change

💉 BMS bets on Tubulis, Moderna and IBM bet on quantum computing; Natco Pharma bets on Indonesia

💊 Fresh funding for healthcare-focused European VCs; Regulatory harmonisation for LatAm; Vaccine hesitancy cause for concern

💊 GSK acquires Bellus Health and its cough drug; US FDA revises Covid vaccine authorisations; Immunisation programmes take a hit

💊 India’s NITI Aayog recommends new drug regulation standards; Sanofi gives Ghana affordable insulin; The fight against hep C gets $$$

💊 Merck makes a big purchase; GSK’s UTI antibiotic sees success; Brazil reengineers mosquito population

💉Pfizer teams up with Sinopharm; WHO seeks to manage infodemics, and protect healthcare workers in Africa

💊 Novo Nordisk’s diabetes battle grows stronger; Biogen takes on Alzheimer’s; SII back to AZ's Covid vaccines

💊 No early success for Moderna’s flu vaccine; Glenmark looks to sell API subsidiary stake; Sobi leaves AstraZeneca, redials Sanofi

💊 Project NextGen prepares for the future of Covid; Temasek becomes majority stakeholder in India’s Manipal hospital chain

💊 IKEA builds more than just furniture; CO2 levels go through the roof; Brazil continues to lose tree cover

💉India becomes 50% more obese; Nigeria to bring in vaccine manufacturing regs; Kenya to import drugs from Pakistan

💊 Pfizer’s RSV vaccine success; US FDA tackles drug shortages; Mapping the Marburg mayhem

💊 TB vaccines need more investment; Pfizer and BioNTech slapped with patent lawsuit; Sanofi gets new flu shot facility

💊 BioNTech jumps aboard the ADC train; Takeda takes on gluten; Merck and Seagen find new ways to be together

💊 Kenyan pharma making moves; Canadian healthcare failing babies; Africa proof of climate change-disease connect

💉 Africa CDC launches outbreak warning system; US FDA launches Lupus Research Alliance; GSK launches attack on yeast infections

💊 J&J’s Janssen steps out of RSV vaccine race; UK government hands out pharma grants; China releases more Covid origin data

💊 India cancels 18 pharma licenses; Novartis cycles its way to cancer drugs; Getting schooled by the WHO

💊 Pfizer pulls out of cancer drug alliance with Merck KGaA; Neuralink seeks brains to stick implants in; US pins hopes on its bioeconomy

💊 Bayer says no to women's health; Novo Nordisk says yes to higher dose of Semaglutide; Antibiotics not helpful in viral infections

💉 J&J’s attempt to extend TB drug patent in India rejected; Genentech’s biologics plant winds down; Moderna moves beyond Covid

💊 Novo Nordisk and Dewpoint collaborate on biomolecular condensates; Roche and Lilly band up to validate Alzheimer's blood test; J&J MedTech setting up shop in KSA

💊 Novo Nordisk under the regulatory scanner in the UK; Tanzania reports a Marburg disease outbreak; The UN's WASH SDGs unlikely to materialise

💊 BioNTech pumps in $200 million into new cancer pact; Olympus gets yet another endoscope warning letter from the US FDA; California signs deal to make its own insulin

💊 Amgen extends layoffs season; Covid may have begun with dogs; India staring at a Covid wave?

💉 Sanofi latest to cut insulin prices; AstraZeneca India tries to cut workforce; Novo Nordisk UK cut from pharma association

💊 Brazil says yes to Takeda’s dengue vaccine; Europe says no to paying Pfizer more money; Researchers say maybe to sucralose

💊 Novartis looks to offload eye drugs; Google digs deeper into AI; Europe wants to bring API production back home

💊 Pfizer makes a big, big bet on Seagen and its ADC; Sanofi makes a much more modest bet on diabetes; Developed countries bet on exporting pollution

💊 South Africa’s patent laws need reform; Moderna fails to shirk patent lawsuit; Prostate cancer may not need treatment

💉 Pasteur Institute’s Chinese break up; WHO’s fight against salt; CSIR’s research grants for women

💊 WHO fires racist Regional Director; J&J fires med-tech employees; Japanese researchers fire mum

💊 Moderna says investors funded its vaccine; Africa's PANTHER looks to make clinical trials faster; Everybody is breathing in horrible air

💊 Plasticosis makes a debut in the wild; Novartis makes another gene therapy bet; AI reimagines present drugs for future pandemics

💊 Pandemic accord negotiations begin; World Bank finances India’s health sector initiatives; AI advances breast cancer treatment research

💉 The US FDA wants to harmonise drug production; The UN wants to protect a million species; Pfizer and Moderna might be forced to cancel their vaccine price hikes

💊 Lilly brings down insulin costs in the US; How to prevent a bird flu pandemic; Eating vegetarian for the planet

💊 Novovax struggling to stay afloat; Humans struggling to breathe; Smokers struggling to smoke

💊 Cancer expensive; Improving self-image cheap; Killing tumours priceless

💊 Life in the time of cholera; Life in the time of bird flu; Life after the time of Covid

💉Maternal mortality numbers are frightening; Infant mortality numbers are frightening too; Also frightening? Fraud in medical research

💊 India's Galentic Pharma gets a WHO alert, Roche and others fail clinical trials; Exercise today, remember tomorrow

💊 Climate change makes Internet bad; HIV makes Mpox worse; A Kenyan affair

💊Africa CDC gets a director general; Leukaemia patients get an HIV cure; Monogamous species get divorces

💊 Pfizer+Valneva cut participants from Lyme disease trial; US FDA gives Cipla 8 new observations; Malaria mosquites learn to travel more

💉 Moderna goes free in the US; Moderna's flu vaccine works, and doesn't; US doctors thumb their noses at biosimilars

💊 Bavarian Nordic goes travelling for vaccines; Africa CDC seeks Pandemic Fund inclusion; A new approach to preventing pandemics

💊 The Kable says hi to Nigeria; GSK says bye to Vir Bio; WHO says au revoir to Covid origin stories

💊 Bangladesh gets an insulin deal; Flu gets a needle-free vaccine; Gavi gets a new CEO; Will you be our Valentine?

💊 Africa CDC seeks young blood; A professor wants Japanese elderly to die; Cancer on your breath

💉 AstraZeneca looks to move away from Covid drugs; Antibiotics to prevent sepsis deaths; Japan goes big on vaccines

💊 Asia uses half the world's energy; Two-thirds of the world's hunger hotspots are in Africa; A deep dive into Mexico

💊 Antibiotic resistance made worse by climate change; Africa CDC ramps up its local manufacturing initiatives; BP says climate? What climate?

💊 Deloitte says R&D productivity in pharma is down; GSK says diversity in clinical trials is a downer; Experts say masks need to be up, not down

💊 Indian pharma (Global Pharma) takes a beating; Cholera lands in South Africa; The Pandemic Fund ready to actually release funds

💉 More bad news for made in India drugs; Half a million lives lost in the Sahel to spurious drugs; CEPI makes another investment

💊 A Kable look at India's budget and what it means for the life sciences; The US hosts a whole raft of fungi; The WHO's new pandemic deal

💊 Pfizer records $100 billion in revenue; The WHO creates a record of TB patients; The Indonesian transformation

💊 Philips lays off 10,000; Sanofi says bye to people in India; Argentina gets a cannabis regulator

💊 SK bioscience launches a tech transfer model for vaccines; A Lilly boost for LMIC cold chains; Happy Neglected Tropical Diseases Day, everyone

💉 Demystifying long Covid; Digihealth funding goes down, down, down; Making skin smarter

💊 Merck pauses prostate cancer trials; Merck cheers for biliary tract cancer; Seaweed to kill cancer

💊 Africa CDC makes a digital play; Torrent says new year, same old day; Study says nasal drug delivery is the new way

💊 WHO seeks action on drug quality from every nation; WHO cautions the world about trans fat elimination; Metabolic bone disease now gets early identification

💊 AI develops unnatural proteins; Cancer remnants that CAR-T cleans; Immunodeficiency is all in your genes

💉 Gavi's new innovation accelerator; Senegal gets CEPI's millions; A new herbal cure for cancer

💊 Sanofi's new global scholarship programme launches; J&J's HIV vaccine will never launch; India's CDSCO says Maiden Pharma drugs are of low quality

💊 Pfizer's philanthropic pursuits; Gates Foundation goes further; TB to be or not to be?

💊 UK drug pricing arrangement sees a massive blow; Research says being upset makes you more clear-headed

💊 Medical facilities need more electricity, says the WHO; Our vaccine needs no more orders, says J&J; Heart attacks don't need cures anymore, say researchers

💉 Bayer to use quantum processing for drug discovery; Novozymes plots a partnership to nix plastic; Africa gets its first cancer tests

💊 Sanofi's biotech investment fund grows bigger; The WHO red-flags India's Marion Biotech; A call for clean air

💊 BioNTech dives deeper into digital; Genome sequencing for the flu is here; A recession looms

💊 AstraZeneca, Ipsen, Chiesi all open their wallets; The parasite extinction; Oral insulin en route

💊 Covid is airborne, says Malaysia; BioNTech working on cancer research with the UK; Keep pets, stay young

💉 Sanofi-AZ make more headway in RSV; GSK to make cancer antibodies with WuXi

💊 Moderna makes a purchase; France makes clean air legal; Swab your nose for viruses

💊 Gilead keeps dreaming the autoimmune dream; Merck's autoimmune candidate shines in its new home

💊 The World Bank asks for more money to fight climate change; One hormone that possibly controls men's health

💊 The first Paxlovid generic gets a nod; Drug shortages around the world; Israel says yes to plastic